Enhancing Elderly DiaβCare: Pharmacist-Initiated Counselling and SMS Reminders Impact on Medication Adherence and Clinical Outcomes

Authors

  • Prof. Ponnusankar S Dept. of Pharmacy Practice, JSS College of Pharmacy, Ooty, The Nilgiris, Tamil Nadu
  • Dr. Suguna K Dept. of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty – 643001, The Nilgiris, Tamil Nadu, India.
  • Mr. Vishwas H N Dept. of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty – 643001, The Nilgiris, Tamil Nadu, India.
  • Dr. Balasubramaniam V Dept. of Emergency Medicine, Govt. Medical College & Hospital, Ooty – 643001, The Nilgiris, Tamil Nadu, India.

DOI:

https://doi.org/10.31351/vol34iss4pp57-65

Keywords:

Medication adherence, Pharmacist counseling, Message reminder services, Clinical outcomes, T2DM, Diabetes care service

Abstract

Medication non-adherence is a significant challenge in chronic diseases such as type 2 diabetes mellitus (T2DM), particularly among elderly patients, leading to increased healthcare costs and adverse outcomes. This study aimed to assess the impact of pharmacist-led counselling and short message service (SMS) reminders on medication adherence and clinical outcomes in newly diagnosed elderly patients with T2DM. A 12-month prospective, open-label, randomized controlled study was conducted at an outpatient diabetic clinic, with 340 participants randomly assigned to either the Diaβcare or usual care groups. The Diaβcare group received pharmacist counselling sessions and SMS reminders, while the usual care group received standard care. Medication adherence and clinical outcomes, including HbA1C, random blood sugar (RBS), fasting blood sugar (FBS), blood pressure (BP), low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides (TG), and body mass index (BMI), were assessed. Statistical analysis used: Sociodemographic characteristics were compared using the Z-test, medication adherence was analysed using the Mann–Whitney test, and clinical outcomes were compared using the t-test (P < 0.05, IBM SPSS v21.0). The Diaβcare group demonstrated significantly improved medication adherence (12.2±7.1%) compared to the control group (0.75±10.2%) (P<0.001). Furthermore, significant reductions in HbA1C, systolic blood pressure (SBP), and LDL cholesterol levels were observed in the Diaβcare group compared to the usual care group (P<0.01). Pharmacist-led Diaβcare effectively enhanced medication adherence and improved clinical outcomes in elderly patients with T2DM. Collaborative efforts among healthcare providers, policymakers, and technologists are essential for scaling up such interventions to enhance global health outcomes.

How to Cite

1.
Sivasankaran P, Kotte S, Hunsur Nagendra V, Vishwanathan B. Enhancing Elderly DiaβCare: Pharmacist-Initiated Counselling and SMS Reminders Impact on Medication Adherence and Clinical Outcomes. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2025 Dec. 20 [cited 2025 Dec. 21];34(4):57-65. Available from: https://www.bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3742

Publication Dates

Received

2024-05-14

Revised

2024-06-18

Accepted

2024-08-11

Published Online First

2025-12-20

References

Chisholm-Burns MA, Kim Lee J, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010; 48(10):923-933. doi: 10.1097/MLR.0b013e3181e57962.

Hyder KM, Mohan J, Varma V, Ponnusankar S, Raja D. Impact of prediabetes education program on Knowledge, attitude and practice among prediabetic population of south India. Prev Med Rep. 2021; 23:101395. doi: 10.1016/j.pmedr.2021.101395.

Mohsina H, Raja D, Jithin M, Ponnusankar S. Assessing the Knowledge, Attitude and Practice (KAP) among the newly diagnosed Prediabetes screened in selected districts of South India. Int J Res Pharm Sci. 2020; 11(3):4836-4846. doi: 10.26452/ijrps.v11i3.2780.

Ravi R, Balasubramaniam V, Kuppusamy G, Ponnusankar S. Current concepts and clinical importance of glycemic variability. Diabetes Metab Syndr. 2021; 15(2):627-636. doi: 10.1016/j.dsx.2021.03.004.

Diabetes [Internet]. World Health Organization; 2023 [updated 2023 April 05; cited 2024 Apr 17]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes

Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021; 69(11):2932-2938. doi: 10.4103 /ijo. IJO _ 1627 _21.

India diabetes report 2000 - 2045 [Internet]. IDF diabetes atlas 10th edition 2021[cited 2024 Apr 17]. Available from: https:// diabetesatlas .org/ data/ en/country/93/in.html

S.S. Chua and S.P. Chan. Medication adherence and achievement of glycaemic targets in ambulatory type 2 diabetic patients. J Appl Pharm Sci Res. 2011; 01(4):55-59. Available from: https:// japsonline .com/ abstract .php? article _id=60&sts=2

Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization; 2003. Available from: https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf

Cramer JA. Importance of medication adherence in type 2 diabetes mellitus management: A systematic review of adherence with medications for diabetes. Diabetes Care. 2004; 27(5):1218-1224. doi: 10.2337/ diacare. 27. 5. 1218

Haghighinejad H, Liaghat L, Malekpour F, Jafari P, Taghipour K, Rezaie M, et al., Comparing the effects of SMS-based education with group-based education and control group on diabetes management: a randomized educational program. BMC Prim Care. 2022; 23(1):209. doi: 10.1186/s12875-022-01820-w

Nikpour S, Mehrdad N, Sanjari M, Aalaa M, Heshmat R, Khabaz Mafinejad M, Larijani B, Nomali M, Najafi Ghezeljeh T. Challenges of Type 2 Diabetes Mellitus Management From the Perspective of Patients: Conventional Content Analysis. Interact J Med Res. 2022 Oct 27;11(2):e41933. doi: 10.2196/41933.

Factors contributing to medication non-adherence among elderly individuals with T2DM:Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013; 4:91. doi: 10.3389/fphar.2013.00091.

Watterson JL, Rodriguez HP, Shortell SM, Aguilera A. Improved Diabetes Care Management Through a Text-Message Intervention for Low-Income Patients: Mixed-Methods Pilot Study. JMIR Diabetes. 2018; 3(4):e15. doi: 10.2196/diabetes.8645

International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: IDF [updated 2020 March 02; cited 2024 Apr 17]. 2019. Available from: https:// www. Diabetesatlas .org/ upload/ resources /material/ 20200302 _133351_ IDFATLAS9e-final-web.pdf

Goruntla N, Mallela V, Nayakanti D. Impact of Pharmacist-directed Counseling and Message Reminder Services on Medication Adherence and Clinical Outcomes in Type 2 Diabetes Mellitus. J Pharm Bioallied Sci. 2019; 11(1):69-76. doi: 10.4103/jpbs.JPBS_211_18

Aceti VM, Santoro RV, Velarde LGC, Brandão DN, da Cruz RA Filho, Taboada GF. Educating diabetic patients through an SMS intervention: a randomized controlled trial at a Brazilian public hospital. Arch Endocrinol Metab. 2021; 65(6):695-703. doi: 10.20945/2359-3997000000390.

Haghighinejad H, Liaghat L, Malekpour F, Jafari P, Taghipour K, Rezaie M, et al. Comparing the effects of SMS-based education with group-based education and control group on diabetes management: a randomized educational program. BMC Prim Care. 2022; 23(1):209. doi: 10.1186/s12875-022-01820-w

Shariful Islam SM, Niessen LW, Ferrari U, Ali L, Seissler J, Lechner A. Effects of Mobile Phone SMS to Improve Glycemic Control Among Patients With Type 2 Diabetes in Bangladesh: A Prospective, Parallel-Group, Randomized Controlled Trial. Diabetes Care. 2015; 38(8):e112-3. doi: 10.2337/dc15-0505

Custodio R, Victorino JN, Justina Estuar MR. The efficacy of an EMR-enabled text messaging system to the expanded health beliefs, diabetes care profile and hba1c of diabetes mellitus patients. Procedia Comput Sci. 2018;138:143–152. doi: 10.1016/j.procs.2018.10.021

Pednekar P, Heller DA, Peterson AM. Association of Medication Adherence with Hospital Utilization and Costs Among Elderly with Diabetes Enrolled in a State Pharmaceutical Assistance Program. J Manag Care Spec Pharm. 2020; 26(9):1099-1108. doi: 10.18553/jmcp.2020.26.9.1099.

Downloads

Published

2025-12-20

Issue

Section

Article